Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor

Justin J. Hill, Nutan Kolluri, Takanori Hashimoto, Qiang Wu, Allan R. Sampson, Lisa M. Monteggia, David A. Lewis

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: The messenger ribonucleic acid (mRNA) for brain-derived neurotrophic factor (BDNF), a regulator of pyramidal neuron dendritic spine density during development, is decreased in the prefrontal cortex of subjects with schizophrenia, and the level of BDNF mRNA expression is positively correlated with dendritic spine density in the same subjects. Methods: To determine whether reduced BDNF mRNA expression might account for decreased spine density in schizophrenia, a knockout of the BDNF gene was induced in mice during embryogenesis or at 12 weeks of age. Quantitative assessments were made of the dendritic arbor of Golgi-impregnated pyramidal neurons in the prelimbic and anterior cingulate cortices in adulthood. Results: Despite an 80% reduction in BDNF mRNA levels in both knockouts, neither spine density nor other dendritic or somal measures were decreased compared with wild-type animals. Conclusions: A reduction in BDNF expression alone does not seem to be sufficient to alter pyramidal neuron morphology in mice. This finding suggests that other molecular abnormalities are also required to produce the pyramidal neuron dendritic spine abnormalities observed in schizophrenia.

Original languageEnglish (US)
Pages (from-to)932-934
Number of pages3
JournalBiological Psychiatry
Volume57
Issue number8
DOIs
StatePublished - Apr 15 2005

Fingerprint

Pyramidal Cells
Brain-Derived Neurotrophic Factor
Dendritic Spines
RNA
Schizophrenia
Spine
Wild Animals
Gyrus Cinguli
Prefrontal Cortex
Embryonic Development
Genes

Keywords

  • BDNF
  • Dendritic spine
  • Inducible knockout
  • Prefrontal cortex
  • Pyramidal neuron
  • Schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Hill, J. J., Kolluri, N., Hashimoto, T., Wu, Q., Sampson, A. R., Monteggia, L. M., & Lewis, D. A. (2005). Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor. Biological Psychiatry, 57(8), 932-934. https://doi.org/10.1016/j.biopsych.2005.01.010

Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor. / Hill, Justin J.; Kolluri, Nutan; Hashimoto, Takanori; Wu, Qiang; Sampson, Allan R.; Monteggia, Lisa M.; Lewis, David A.

In: Biological Psychiatry, Vol. 57, No. 8, 15.04.2005, p. 932-934.

Research output: Contribution to journalArticle

Hill, JJ, Kolluri, N, Hashimoto, T, Wu, Q, Sampson, AR, Monteggia, LM & Lewis, DA 2005, 'Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor', Biological Psychiatry, vol. 57, no. 8, pp. 932-934. https://doi.org/10.1016/j.biopsych.2005.01.010
Hill, Justin J. ; Kolluri, Nutan ; Hashimoto, Takanori ; Wu, Qiang ; Sampson, Allan R. ; Monteggia, Lisa M. ; Lewis, David A. / Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor. In: Biological Psychiatry. 2005 ; Vol. 57, No. 8. pp. 932-934.
@article{7da74c8015514e9e82b052feb73091ec,
title = "Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor",
abstract = "Background: The messenger ribonucleic acid (mRNA) for brain-derived neurotrophic factor (BDNF), a regulator of pyramidal neuron dendritic spine density during development, is decreased in the prefrontal cortex of subjects with schizophrenia, and the level of BDNF mRNA expression is positively correlated with dendritic spine density in the same subjects. Methods: To determine whether reduced BDNF mRNA expression might account for decreased spine density in schizophrenia, a knockout of the BDNF gene was induced in mice during embryogenesis or at 12 weeks of age. Quantitative assessments were made of the dendritic arbor of Golgi-impregnated pyramidal neurons in the prelimbic and anterior cingulate cortices in adulthood. Results: Despite an 80{\%} reduction in BDNF mRNA levels in both knockouts, neither spine density nor other dendritic or somal measures were decreased compared with wild-type animals. Conclusions: A reduction in BDNF expression alone does not seem to be sufficient to alter pyramidal neuron morphology in mice. This finding suggests that other molecular abnormalities are also required to produce the pyramidal neuron dendritic spine abnormalities observed in schizophrenia.",
keywords = "BDNF, Dendritic spine, Inducible knockout, Prefrontal cortex, Pyramidal neuron, Schizophrenia",
author = "Hill, {Justin J.} and Nutan Kolluri and Takanori Hashimoto and Qiang Wu and Sampson, {Allan R.} and Monteggia, {Lisa M.} and Lewis, {David A.}",
year = "2005",
month = "4",
day = "15",
doi = "10.1016/j.biopsych.2005.01.010",
language = "English (US)",
volume = "57",
pages = "932--934",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor

AU - Hill, Justin J.

AU - Kolluri, Nutan

AU - Hashimoto, Takanori

AU - Wu, Qiang

AU - Sampson, Allan R.

AU - Monteggia, Lisa M.

AU - Lewis, David A.

PY - 2005/4/15

Y1 - 2005/4/15

N2 - Background: The messenger ribonucleic acid (mRNA) for brain-derived neurotrophic factor (BDNF), a regulator of pyramidal neuron dendritic spine density during development, is decreased in the prefrontal cortex of subjects with schizophrenia, and the level of BDNF mRNA expression is positively correlated with dendritic spine density in the same subjects. Methods: To determine whether reduced BDNF mRNA expression might account for decreased spine density in schizophrenia, a knockout of the BDNF gene was induced in mice during embryogenesis or at 12 weeks of age. Quantitative assessments were made of the dendritic arbor of Golgi-impregnated pyramidal neurons in the prelimbic and anterior cingulate cortices in adulthood. Results: Despite an 80% reduction in BDNF mRNA levels in both knockouts, neither spine density nor other dendritic or somal measures were decreased compared with wild-type animals. Conclusions: A reduction in BDNF expression alone does not seem to be sufficient to alter pyramidal neuron morphology in mice. This finding suggests that other molecular abnormalities are also required to produce the pyramidal neuron dendritic spine abnormalities observed in schizophrenia.

AB - Background: The messenger ribonucleic acid (mRNA) for brain-derived neurotrophic factor (BDNF), a regulator of pyramidal neuron dendritic spine density during development, is decreased in the prefrontal cortex of subjects with schizophrenia, and the level of BDNF mRNA expression is positively correlated with dendritic spine density in the same subjects. Methods: To determine whether reduced BDNF mRNA expression might account for decreased spine density in schizophrenia, a knockout of the BDNF gene was induced in mice during embryogenesis or at 12 weeks of age. Quantitative assessments were made of the dendritic arbor of Golgi-impregnated pyramidal neurons in the prelimbic and anterior cingulate cortices in adulthood. Results: Despite an 80% reduction in BDNF mRNA levels in both knockouts, neither spine density nor other dendritic or somal measures were decreased compared with wild-type animals. Conclusions: A reduction in BDNF expression alone does not seem to be sufficient to alter pyramidal neuron morphology in mice. This finding suggests that other molecular abnormalities are also required to produce the pyramidal neuron dendritic spine abnormalities observed in schizophrenia.

KW - BDNF

KW - Dendritic spine

KW - Inducible knockout

KW - Prefrontal cortex

KW - Pyramidal neuron

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=16844385099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16844385099&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2005.01.010

DO - 10.1016/j.biopsych.2005.01.010

M3 - Article

C2 - 15820715

AN - SCOPUS:16844385099

VL - 57

SP - 932

EP - 934

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 8

ER -